| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |